Solid Tumors Trials

Bayer 20324 ON-TRK

ON-TRK: PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib

BMS CA209-76U

A phase 1/2, pharmacokinetic multi-tumor study of subcutaneous formulation of ipilimumab monotherapy and in combination with subcutaneous nivolumab

Fort Wayne North Office
(260) 484-8830
2514 E Dupont Road, Suite 100
Fort Wayne, IN 46825

Fort Wayne South Office
(260) 436-0800
7910 West Jefferson Boulevard, Suite 108
Fort Wayne, Indiana 46804

©2019 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.